|
|
|
LifeScienceHistory.com - Check us out on Instagram
New York Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing New YorkLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Mustang Bio, Inc.
| | | Phone: | (781) 652-4500 | Year Established: | 2015 | Ticker: | FBIO | Exchange: | NASDAQ | Main Contact: | Manuel Litchman, M.D., President & CEO | | Other Contacts: | Knut Niss, Ph.D., CTO Sadik Kassim, Ph.D., CSO Michael S. Weiss, Chairman Brian Achenbach, VP, Finance & Corporate Controller Martina A. Sersch, M.D., Ph.D., CMO
| | Company Description | Mustang Bio, a Fortress Biotech company, is a clinical-stage biopharmaceutical company developing novel immunotherapies based on the ground breaking Chimeric Antigen Receptor (CAR) research of Dr. Stephen Forman and Dr. Christine Brown of City of Hope, an NCI-designated Comprehensive Cancer Center. Mustang was formed to help bring this pioneering CAR research to as many patients as possible. Mustang, through a research agreement with COH, will develop CARs across multiple cancers, including for AML and Brain Cancer. Both of the lead programs are in phase I clinical trials. | |
|
|
|
|
|